Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Lo Sardo

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 22, 2023
Co-Immunoprecipitation (Co-Ip) in Mammalian CellsFederica Lo Sardo
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2020
The Chromosome Conformation Capture (3C) in Drosophila melanogasterFederica Lo Sardo
Cell Cycle (Georgetown, Tex.)|March 17, 2012
Concerted epigenetic signatures inheritance at PcG targets through replicationChiara Lanzuolo, Federica Lo Sardo, Valerio Orlando
Cancers|May 9, 2018
YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical TargetingFederica Lo Sardo, Sabrina Strano, Giovanni Blandino
International Journal of Molecular Sciences|September 8, 2017
Melatonin and Hippo Pathway: Is There Existing Cross-Talk?Federica Lo Sardo, Paola Muti, Giovanni Blandino, et al.
Plos Genetics|November 11, 2011
PcG complexes set the stage for epigenetic inheritance of gene silencing in early S phase before replicationChiara Lanzuolo, Federica Lo Sardo, Adamo Diamantini, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|July 1, 2022
YAP and TAZ: Monocorial and bicorial transcriptional co-activators in human cancersFederica Lo Sardo, Valeria Canu, Marcello Maugeri-Saccà, et al.
Plos Genetics|February 26, 2013
PcG-mediated higher-order chromatin structures modulate replication programs at the Drosophila BX-CFederica Lo Sardo, Chiara Lanzuolo, Federico Comoglio, et al.
Cancer Letters|December 9, 2020
YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancerFederica Lo Sardo, Claudio Pulito, Andrea Sacconi, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 31, 2024
Polo-like kinase 2 targeting as novel strategy to sensitize mutant p53-expressing tumor cells to anticancer treatmentsFabio Valenti, Federica Ganci, Andrea Sacconi, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|May 22, 2023
Co-Immunoprecipitation (Co-Ip) in Mammalian CellsFederica Lo Sardo
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2020
The Chromosome Conformation Capture (3C) in Drosophila melanogasterFederica Lo Sardo
Cell Cycle (Georgetown, Tex.)|March 17, 2012
Concerted epigenetic signatures inheritance at PcG targets through replicationChiara Lanzuolo, Federica Lo Sardo, Valerio Orlando
Cancers|May 9, 2018
YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical TargetingFederica Lo Sardo, Sabrina Strano, Giovanni Blandino
International Journal of Molecular Sciences|September 8, 2017
Melatonin and Hippo Pathway: Is There Existing Cross-Talk?Federica Lo Sardo, Paola Muti, Giovanni Blandino, et al.
Plos Genetics|November 11, 2011
PcG complexes set the stage for epigenetic inheritance of gene silencing in early S phase before replicationChiara Lanzuolo, Federica Lo Sardo, Adamo Diamantini, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|July 1, 2022
YAP and TAZ: Monocorial and bicorial transcriptional co-activators in human cancersFederica Lo Sardo, Valeria Canu, Marcello Maugeri-Saccà, et al.
Plos Genetics|February 26, 2013
PcG-mediated higher-order chromatin structures modulate replication programs at the Drosophila BX-CFederica Lo Sardo, Chiara Lanzuolo, Federico Comoglio, et al.
Cancer Letters|December 9, 2020
YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancerFederica Lo Sardo, Claudio Pulito, Andrea Sacconi, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 31, 2024
Polo-like kinase 2 targeting as novel strategy to sensitize mutant p53-expressing tumor cells to anticancer treatmentsFabio Valenti, Federica Ganci, Andrea Sacconi, et al.
Pageof 2